Clinical trial Recruiting at 1 site Observational Ages 18 and up

Understanding head and neck cancer through detailed cellular analysis

Official title: An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

Run by University of Southern California · NCT06420219 · Data updated 2026-11-12

This study looks at the cells in head and neck cancer to see how they behave in patients with HPV-related throat cancer and their lymph nodes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity of Southern California
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedMarch 25, 2024
Main results expectedMarch 25, 2028
Study endsMarch 25, 2029
Registry record updatedApril 28, 2026
Trial IDNCT06420219 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with a new diagnosis of head and neck cancer who have not received prior treatment.

Probably not a fit

Patients who have previously undergone treatment for head and neck cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the high-resolution single-cell profiling of cancer-associated fibroblasts in patients with HPV-positive oropharyngeal squamous cell carcinoma and their metastatic lymph nodes. Participants will undergo photography, blood sample collection, and tissue collection, while their medical records will be reviewed to gather comprehensive data on the disease. The aim is to evaluate the cellular and biomarker characteristics associated with the aggressive behavior of head and neck cancer.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and treatment strategies for head and neck cancer.

How similar studies have gone: Other studies have shown promise in using multi-omic approaches to understand cancer biology, suggesting potential for success in this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis/disease status: New diagnosis of head and neck cancer
* Allowable type and amount of prior therapy: No prior treatment
* Age ≥ 18 years.
* Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

* Patients who have had treatment of head and neck cancer

Where it's running

  • USC / Norris Comprehensive Cancer Center
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.